angiotensin ii, des-phe(8)- has been researched along with Malignant Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Červenka, L; Červenková, L; Doleželová, Š; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Nishiyama, A; Sadowski, J; Škaroupková, P; Vaňourková, Z | 1 |
| Červenka, L; Doleželová, Š; Falck, JR; Husková, Z; Imig, JD; Jíchová, Š; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Neckář, J; Reddy, RN; Sadowski, J; Vernerová, Z | 1 |
2 other study(ies) available for angiotensin ii, des-phe(8)- and Malignant Hypertension
| Article | Year |
|---|---|
Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Topics: Albuminuria; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Body Weight; Cytochrome P-450 CYP1A1; Diminazene; Enzyme Activators; Gene Expression Regulation; Hypertension, Malignant; Kidney; Mice; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Sodium | 2016 |
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Albuminuria; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP1A1; Hypertension, Malignant; Indoles; Kidney; Male; Peptide Fragments; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Time Factors | 2016 |